FDA Outlines Path Forward for Verve’s Lead Candidate, VERVE-101

[cafead]

via The FDA appears to be taking an ultra-cautious approach with base editing technology. Monday, Verve Therapeutics revealed that the FDA has officially requested several buckets of additional safety information to lift the hold on its lead candidate, VERVE-101.

article source